residual cancer

residual cancer

Oncology Any CA that remains after definitive management has been attempted. Cf Recurrent cancer.
References in periodicals archive ?
Tussing continued, "In contrast to 'off-the-shelf' immunotherapies that are not patient-specific, OncoVAX is an autologous cancer vaccine manufactured with a patented process to leverage a patient's own live and metabolically active tumor cells to launch a potent and customized immune response against residual cancer cells that may reside in the body after surgery.
By enabling surgeons to remove sub-millimeter residual cancer, we expect to improve patient outcomes.
At the same time, ATIR (TM) contains potential cancer killing T-cells from the donor that could eliminate residual cancer cells and avoid the return of the disease.
But they're a reminder there's something there keeping any residual cancer cells at bay, so it's a love-hate relationship.
1,3,5-8) Estimation of percent neoplastic cellularity can also affect care in other diagnostic settings, including assessment of copy number variation, chromosomal translocation, determination of residual cancer burden after neoadjuvant therapy, (9-12) and other genomic aberrations that can be affected by contaminating normal DNA.
Cesium-131 seeded mesh is a form of cancer fighting radiation therapy that is implanted at the time of surgical removal of tumors and immediately attacks the residual cancer cells.
Our findings suggest that the oncological risk of leaving behind residual cancer may not justify the practice of prostate-sparing cystectomy as standard of care and that this procedure should be reserved for highly motivated and highly selected patients.
Not only does the virus kill cancer cells directly, but it also triggers an immune response - like a vaccine - that helps eliminate residual cancer cells.
This isn't as crucial if you have DCIS (ductal carcinoma in situ), as it won't necessarily reduce residual cancer cells.
Fourteen patients' tumours shrank, while 93 per cent had no trace of residual cancer in thei r lymph nodes.
In these studies, cancer treatment centers have typically addressed cleaning the stem cells without considering how much residual cancer is still present in the patient.
Rather than using PET scans to detect residual cancer only after all other methodologies--including empiric RAI therapy--have not revealed a recurrence, "we're now saying, before you do RAI, you may do a PET scan, especially if the serum thyroglobulin is above 10 ng/mL," he said.